Pladevall-Morera, D.;                     Castejón-Griñán, M.;                     Aguilera, P.;                     Gaardahl, K.;                     Ingham, A.;                     Brosnan-Cashman, J.A.;                     Meeker, A.K.;                     Lopez-Contreras, A.J.    
        ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. Cancers 2022, 14, 1790.
    https://doi.org/10.3390/cancers14071790
    AMA Style
    
                                Pladevall-Morera D,                                 Castejón-Griñán M,                                 Aguilera P,                                 Gaardahl K,                                 Ingham A,                                 Brosnan-Cashman JA,                                 Meeker AK,                                 Lopez-Contreras AJ.        
                ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. Cancers. 2022; 14(7):1790.
        https://doi.org/10.3390/cancers14071790
    
    Chicago/Turabian Style
    
                                Pladevall-Morera, David,                                 MarÃa Castejón-Griñán,                                 Paula Aguilera,                                 Karina Gaardahl,                                 Andreas Ingham,                                 Jacqueline A. Brosnan-Cashman,                                 Alan K. Meeker,                                 and Andres J. Lopez-Contreras.        
                2022. "ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors" Cancers 14, no. 7: 1790.
        https://doi.org/10.3390/cancers14071790
    
    APA Style
    
                                Pladevall-Morera, D.,                                 Castejón-Griñán, M.,                                 Aguilera, P.,                                 Gaardahl, K.,                                 Ingham, A.,                                 Brosnan-Cashman, J. A.,                                 Meeker, A. K.,                                 & Lopez-Contreras, A. J.        
        
        (2022). ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. Cancers, 14(7), 1790.
        https://doi.org/10.3390/cancers14071790